C68 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Crescent Biopharma Inc

Watchlist Manager

Watchlist

Price: 14.6 EUR

Market Cap: €202.8m

	Crescent Biopharma Inc F:C68	US
F	First Advantage Corp NASDAQ:FA	US
	Chicago Atlantic Real Estate Finance Inc NASDAQ:REFI	US
	Fuelcell Energy Inc F:FEY	US
	Pennon Group PLC F:3PN	UK
	Opendoor Technologies Inc NASDAQ:OPEN	US
F	FormFactor Inc F:FMF	US
	Mitsui Fudosan Co Ltd F:MFU	JP
C	Capital One Financial Corp DUS:CFX	US
A	Alaska Air Group Inc DUS:ALK	US
	Humana Inc NYSE:HUM	US
V	Vestas Wind Systems A/S XMUN:VWSB	DK

Profitability Summary

Crescent Biopharma Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1.341%

Negative 3Y Average Operating Margin

-313.027%

Negative Net Margin

-1.438%

Negative 3Y Average Net Margin

-306.329%

Negative Free Cash Flow Margin

-1.332%

Negative 3Y Average Free Cash Flow Margin

-279.187%

Negative ROE

-150%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-1.896%

Declining ROIC

-1.106% > -1.741%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.